Navigation Links
Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
Date:10/10/2007

angible Assets - Net 1,415 1,229

Noncurrent Deferred Tax Assets 732 625

Other Assets 473 473

Total Assets $12,985 $11,728

Liabilities and Shareowners' Equity

Current Liabilities:

Short-Term Debt, Including Current Portion

of Long-Term Debt $270 $28

Accounts Payable 649 514

Income Taxes Payable 150 234

Accrued Compensation and Benefits 349 295

Accrued Marketing Programs 517 494

Deferred Revenues 260 120

Miscellaneous Short-Term Accruals 880 594

Total Current Liabilities 3,075 2,279

Long-Term Debt 1,150 1,639

Postretirement Liabilities 542 600

Long-Term Portion of Solutia-Related Reserve 119 155

Other Liabilities 594 530

Shareowners' Equity 7,505 6,525

Total Liabilities and Shareowners' Equity $12,985 $11,728

Debt to Capital Ratio: 16% 20%

Monsanto Company

Selected Financial Information

(Dollars in millions)

Unaudited

Statements of Consolidated Cash Flows 12 Months 12 Months

Ended Ended

Aug. 31,
'/>"/>

SOURCE Monsanto
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Privacy, trust still the biggest barriers to electronic record sharing
2. Visions: Wade offers straight talk on e-medical records
3. Portal to e-records boosts care at Childrens Hospital
4. Yasnoff: Wisconsin should invest in health record bank
5. Doyle seeks $30M for e-medical record adoption
6. Impact of e-medical records will be felt at home
7. Epic responds to critics of electronic record installation
8. GE Healthcare launches hybrid electronic record
9. Careful with that electronic health record, Mr. Leavitt
10. Wisconsin companies reach deal on electronic health records
11. Tommy Thompson says capital needed for electronic health records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Amsterdam, May 17, 2013 - Elsevier, a world-leading provider ... today announced the publication of a recent study in ... old human blastocysts showing that those with an abnormal ... which they have developed to blastocysts, thereby classifying the ... new study the same group has undertaken a retrospective ...
(Date:5/17/2013)... 2013 •    First of its kind research ... ,     New facility will help solve crop stresses ... Syngenta unveiled its new crop research facility during ... Innovation Center. The first of its kind, $72 million ... agricultural climate and precisely measure plant inputs – the ...
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)... May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased ... with Switzerland -based Kenta Biotech ... monoclonal antibody (mAb) products, and technologies. This asset ... for treatment of infections by common pathogens including ... , Pseudomonas aeruginosa , Acinetobacter baumannii ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... Decision Resources, one of the world,s leading research and advisory ... uptake of marketed and emerging TNF-alpha inhibitors and interleukin inhibitors ... billion in 2008 to $5.2 billion in 2018 in the ... Japan. , The new Pharmacor report entitled ...
... ... and related products. Wide range of new peptide synthesis reagents and catalogue peptides. New ... , ... October 22, 2009 -- Mimotopes Pty Ltd, a subsidiary of Commonwealth Biotechnologies Inc. (NASDAQ ...
... , MONTREAL, Oct. 23 /PRNewswire/ - Enerkem, a leading ... Corporate Knights 2009 Next 10 Emerging Cleantech Leaders. Vincent ... the other Cleantech companies at today,s Toronto Stock Exchange ... Cleantech Next 10 list features Canada,s best privately held ...
Cached Biology Technology:Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market 2Mimotopes Launches Online Peptide Superstore 2Mimotopes Launches Online Peptide Superstore 3Enerkem Named an Emerging Cleantech Leader in Canada 2
(Date:5/16/2013)... us don,t ponder our pulses outside of the gym. But ... monitor heart health. , Zhenan Bao, a professor of chemical ... a dollar bill and no wider than a postage stamp. ... the wrist, is sensitive enough to help doctors detect stiff ... be used to continuously track heart health and provide doctors ...
(Date:5/16/2013)... May 16, 2013 The consultancy ... on Tuesday to Germany,s largest ... border control system. DERMALOG has been honored ... Practices Award in the category Global Biometrics and Border ... Biometric   Border Control System . One of ...
(Date:5/15/2013)... that have powerful behavioral effects on diverse organisms ... ecosystems, according to a theory proposed in the ... of the theory, Ryan P. Ferrer of Seattle ... University of California at Los Angeles, liken such ... may be uncommon but exert a controlling influence, ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Natural 'keystone molecules' punch over their weight in ecosystems 2
... Partnership, in partnership with the LUNGevity Foundation, is pleased ... grant competition. The research grants, each $100,000, ... biology, risk assessment, prevention, detection, and response to treatment. ... generous donors, were able to offer researchers critical funding ...
... LAKE CITY Two major eye diseases and leading causes ... or even prevented by drugs that activate a protein ... of Utah School of Medicine and several other institutions ... both diseases was prevented and even reversed when the ...
... a systems biological analysis of genome-scale data from ... researchers identified that the master gene controlling the ... study will appear in the latest issue of ... This hypothesis derived from multi-network analysis of Arabidopsis ...
Cached Biology News:National Lung Cancer Partnership and LUNGevity Foundation 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 3Systems biology approach identifies nutrient regulation of biological clock in plants 2
...
Rabbit polyclonal to Quinolinic acid ( Abpromise for all tested applications). Antigen: Synthetic quinolinic acid conjugated to bovine serum albumin....
Human Cell Line Slides...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Biology Products: